Omeros (OMER) Capital Expenditures Growth (5y) (2015 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -31.51% |
| Jun 30, 2025 | -38.18% |
| Mar 31, 2025 | -9.08% |
| Dec 31, 2024 | 10.20% |
| Sep 30, 2024 | -51.94% |
| Jun 30, 2024 | -3.78% |
| Mar 31, 2024 | -20.44% |
| Dec 31, 2023 | 4.88% |
| Sep 30, 2023 | -17.81% |
| Jun 30, 2023 | 6.26% |
| Sep 30, 2022 | -15.87% |
| Dec 31, 2021 | 9.04% |
| Sep 30, 2021 | 18.54% |
| Jun 30, 2021 | 20.95% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 4.78% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 31.28% |
| Jun 30, 2019 | 92.23% |
| Mar 31, 2019 | 97.87% |
| Dec 31, 2018 | 6.78% |
| Sep 30, 2018 | 12.89% |
| Jun 30, 2018 | 189.40% |
| Mar 31, 2018 | 15.77% |
| Sep 30, 2017 | -17.69% |
| Jun 30, 2017 | 27.30% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 3.20% |
| Sep 30, 2016 | 44.43% |
| Jun 30, 2016 | -41.84% |
| Dec 31, 2015 | 2.00% |
| Sep 30, 2015 | -13.87% |